Moderna-Merck Vaccine Data Leaks Ahead of ESMO — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- ESMO opened this year’s conference in Madrid with an unexpected leak of the meeting’s most anticipated data.
- Moderna-Merck melanoma cancer vaccine data arrived early because of a major embargo violation before the scheduled presentation.
- The Moderna-Merck presentation broke loose on the conference’s eve, upending reporters’ carefully laid plans.
- STAT said, “We were NOT the guilty party,” explicitly denying responsibility for the leak.
- STAT said it would cover reactions to the study and other conference developments over the next few days.
Why it matters: ESMO lost control of the timing of its conference’s most anticipated data when the embargo broke on the eve of the meeting. The immediate consequence was concrete: reporters’ planned coverage was disrupted, and STAT says it will track reactions over the next few days using material that arrived before the presentation.
Ask SkimNews
